Literature DB >> 11045392

Enalapril and prednisone in children with nephrotic-range proteinuria.

A Delucchi1, F Cano, E Rodriguez, E Wolff, X Gonzalez, M A Cumsille.   

Abstract

The effect of enalapril and low prednisone doses on the urinary protein electrophoretic pattern was studied in 13 pediatric patients with glomerular diseases and steroid-resistant nephrotic syndrome. Enalapril was administered at doses of 0.2-0.6 mg/kg per day for 24-84 months, and prednisone was introduced 2 months later in 11 patients at doses of 30 mg/m2 on alternate days. The urine protein electrophoretic pattern showed a reduction of 80% and 70% in the total protein and albumin, respectively, after enalapril. Total urinary protein decreased from 5.46 to 1.1 g/m2 per day (P<0.001). A marked change from a pattern of non-selective urinary protein loss to an albumin-selective proteinuria was observed. Mean total plasma proteins increased from 4.7 to 5.43 g/dl (P<0.001). Four patients became free of proteinuria 24 months after enalapril was started, but only 2 remained free of proteinuria at 48 months of follow-up. The other 11 patients had persistent albuminuria of between 0.5 and 2.6 g/m2 per day with a selective urinary electrophoretic pattern. No additional decrease was observed after steroids were introduced. A clinical improvement in edema was observed in all children. Three patients developed transient acute renal failure, during the course of an infectious disease; 2 developed peritonitis and 1 pneumopathy. In these patients withdrawal of enalapril was necessary until a complete recovery of renal function was observed. Four patients were hypertensive on admission, achieving normal blood pressure 1 month after enalapril was started. No episodes of systemic arterial hypotension were seen. Creatinine clearance and serum potassium showed no statistically significant change.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11045392     DOI: 10.1007/s004679900244

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN: 0931-041X            Impact factor:   3.714


  12 in total

1.  Effect of fosinopril in children with steroid-resistant idiopathic nephrotic syndrome.

Authors:  Zhuwen Yi; Zhihui Li; Xiao-Chuan Wu; Qing-Nan He; Xi-Qiang Dang; Xiao-Jie He
Journal:  Pediatr Nephrol       Date:  2006-05-06       Impact factor: 3.714

2.  Renin-angiotensin-aldosterone system inhibitors in pediatric focal segmental glomerulosclerosis.

Authors:  Shreya Kangovi; Meredith Edwards; Stephen Woloszynek; Nandita Mitra; Harold Feldman; Bernard S Kaplan; Kevin E Meyers
Journal:  Pediatr Nephrol       Date:  2011-11-25       Impact factor: 3.714

Review 3.  Pharmacotherapeutic review and update of idiopathic nephrotic syndrome in children.

Authors:  Silvia Manrique-Rodríguez; Cecilia M Fernandez-Llamazares; Maria Sanjurjo-Saez
Journal:  Pharm World Sci       Date:  2010-03-13

4.  Progression of chronic renal failure in children with dysplastic kidneys.

Authors:  Claudia González Celedón; María Bitsori; Kjell Tullus
Journal:  Pediatr Nephrol       Date:  2007-03-23       Impact factor: 3.714

Review 5.  Mycophenolate mofetil therapy in frequently relapsing steroid-dependent and steroid-resistant nephrotic syndrome of childhood: current status and future directions.

Authors:  Asha Moudgil; Arvind Bagga; Stanley C Jordan
Journal:  Pediatr Nephrol       Date:  2005-06-24       Impact factor: 3.714

Review 6.  The management of idiopathic nephrotic syndrome in children.

Authors:  Elisabeth Hodson
Journal:  Paediatr Drugs       Date:  2003       Impact factor: 3.022

7.  Mycophenolate mofetil in children with steroid/cyclophosphamide-resistant nephrotic syndrome.

Authors:  Valderez Raposo de Mello; Maira Tinte Rodrigues; Tais Helena Mastrocinque; Simone Paiva Laranjo Martins; Olberes Vitor Braga de Andrade; Eliana Biondi Medeiros Guidoni; Daniel Kashiwamura Scheffer; Dino Martini Filho; Julio Toporovski; Vanda Benini
Journal:  Pediatr Nephrol       Date:  2010-03       Impact factor: 3.714

Review 8.  Steroid resistant nephrotic syndrome.

Authors:  Sushmita Banerjee
Journal:  Indian J Pediatr       Date:  2002-12       Impact factor: 1.967

9.  Renoprotection by ACE inhibitors after severe hemolytic uremic syndrome.

Authors:  Maria Van Dyck; Willem Proesmans
Journal:  Pediatr Nephrol       Date:  2004-04-03       Impact factor: 3.714

10.  Enalapril dosage in steroid-resistant nephrotic syndrome.

Authors:  Arvind Bagga; Basanagoud D Mudigoudar; Pankaj Hari; Vandita Vasudev
Journal:  Pediatr Nephrol       Date:  2003-11-25       Impact factor: 3.714

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.